EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Challenges of the eighth edition of the American Joint Committee on Cancer staging system for pathologists focusing on early stage lung adenocarcinoma

Yu-Ting Wang, Il-Chi Chang, Chih-Yi Chen, Jiun-Yi Hsia, Frank Cheau-Feng Lin, Wan-Ru Chao, Tuan-Ying Ke, Ya-Ting Chen, Chih-Jung Chen, Min-Shu Hsieh, Shiu-Feng Huang iD

Thoracic Cancer · 2023-02 · 14 (6) · 592-601

DOI: 10.1111/1759-7714.14785 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, online erschienen am 02.01.2023. Verfasst von Yu-Ting Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical Pathology, Chung Shan Medical University Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health and Welfare, National Health Research Institutes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The eighth edition of the American Joint Committee on Cancer (AJCC) staging system for lung cancer adopts new criteria for tumor size, and for determining pTis, pT1a(mi), and pT1a. The latter is based on the size of stromal invasion. It is quite challenging for lung pathologists.

Methods

All patients who had undergone surgical resection for pulmonary adenocarcinoma (ADC) at Chung Shan Medical University Hospital between January 2014 and April 2018 were reviewed, and restaged according to the eighth AJCC staging system. The clinical characteristics and survival of patients with tumor stage 0 (pTis), I or II were analyzed.

Results

In total, 376 patients were analyzed. None of the pTis, pT1a(mi), or pT1a tumors recurred during the follow‐up period up to 5 years, but pT1b, pT1c, pT2a, and pT2b tumors all had a few tumor recurrences ( p < 0.0001). In addition, 95.2%, 100%, and 77.5% of pTis, pT1a(mi), and pT1a tumors, respectively, had tumor sizes ≤1.0 cm by gross examination. All pTis, pT1a(mi), and pT1a tumors exhibited only lepidic, acinar, or papillary patterns histologically.

Conclusions

This study demonstrated excellent survival for lung ADC patients with pTis, pT1a(mi), and pT1a tumors when completely excised. To reduce the inconsistencies between pathologists, staging lung ADC with tumors of ≤1 cm in size grossly as pTis, pT1a(mi), or pT1a may not be necessary when the tumors exhibit only lepidic, acinar, or papillary histological patterns. A larger cohort study with sufficient follow‐up data is necessary to support this proposal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsHumansNeoplasm StagingCohort StudiesPathologistsNeoplasm Recurrence, LocalPrognosisRetrospective Studies

Stichwörter der Autor:innen

AJCC staging systemadenocarcinoma in situlung adenocarcinomaminimally invasive adenocarcinomarecurrence

Autor:innen und Institutionen

  • Department of Anatomical Pathology, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
  • Department of Thoracic Surgery, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Department of Pathology and Laboratory Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan.

ORCID-Profile: Shiu-Feng Huang

Förderung

  • Ministry of Health and Welfare
  • National Health Research Institutes

Zitieren

APA

Wang, Y. T., Chang, I. C., Chen, C. Y., Hsia, J. Y., Lin, F. C., Chao, W. R., Ke, T. Y., Chen, Y. T., Chen, C. J., Hsieh, M. S., & Huang, S. F. (2023). Challenges of the eighth edition of the American Joint Committee on Cancer staging system for pathologists focusing on early stage lung adenocarcinoma. Thoracic Cancer, 14(6), 592-601. https://doi.org/10.1111/1759-7714.14785

Vancouver

Wang YT, Chang IC, Chen CY, Hsia JY, Lin FC, Chao WR, et al. Challenges of the eighth edition of the American Joint Committee on Cancer staging system for pathologists focusing on early stage lung adenocarcinoma. Thoracic Cancer. 2023;14(6):592-601. doi:10.1111/1759-7714.14785

BibTeX
@article{Wang2023,
  author = {Wang, Yu-Ting and Chang, Il-Chi and Chen, Chih-Yi and Hsia, Jiun-Yi and Lin, Frank Cheau-Feng and Chao, Wan-Ru and Ke, Tuan-Ying and Chen, Ya-Ting and Chen, Chih-Jung and Hsieh, Min-Shu and Huang, Shiu-Feng},
  title = {Challenges of the eighth edition of the American Joint Committee on Cancer staging system for pathologists focusing on early stage lung adenocarcinoma},
  journal = {Thoracic Cancer},
  year = {2023},
  volume = {14},
  number = {6},
  pages = {592--601},
  doi = {10.1111/1759-7714.14785}
}
Kostenlos starten →